Catapres Ampoules

Active ingredients: Clonidine

Product name and form

Catapres Ampoules 150 micrograms in 1 ml Solution for Injection.

Pharmaceutical Form

Solution for injection.

Clear, colourless solution.

Qualitative and quantitative composition

Each 1 ml ampoule contains clonidine hydrochloride 150 micrograms.

For excipients, see 6.1.

Active Ingredient
Description

Clonidine has been shown to have both central and peripheral sites of action. With long-term treatment clonidine reduces the responsiveness of peripheral vessels to vasoconstrictor and vasodilator substances and to sympathetic nerve stimulation. Early in treatment, however, blood pressure reduction is associated with a central reduction of sympathetic outflow and increased vagal tone.

List of Excipients

Sodium chloride
1N hydrochloric acid
Water for injections

Pack sizes and marketing

1 ml colourless glass (Ph. Eur. Type I) ampoules, marketed in packs of 5.

Marketing authorization holder

Boehringer Ingelheim Limited
Ellesfield Avenue
Bracknell
Berkshire
RG12 8YS
United Kingdom

Marketing authorization dates and numbers

PL 00015/5008R

10/05/2006

Drugs

Drug
Countries
Australia, Ireland, New Zealand, United Kingdom, United States